Blocking pathway overcomes tumor vessel resistance to radiation

(NASHVILLE, Tenn., August 26, 2002) Blocking a specific signalling pathway with drugs can make blood vessels more susceptible to the effects of radiation and improve tumor control, Vanderbilt-Ingram Cancer Center scientists have demonstrated.

The study, published in the current issue of the journal Cancer Research, shows a potential way to overcome an ironic discovery found in the study. The radiation therapy intended to kill the blood vessels that feed cancer cells can actually trigger a chemical pathway that makes the vessels more resistant to therapy.

"We know that if vascular endothelium is destroyed, tumor control can be improved," said principal investigator Dr. Dennis Hallahan, chairman of Radiation Oncology. "However, the blood vessels are often resistant to the therapy. Our initial hypothesis was that the cell survival pathways that allowed the blood vessels to survive were activated by growth factors from the tumor cells. We were surprised to find that cell survival pathways were activated not only by these growth factors but by the therapy itself." Blood vessels probably developed this mechanism, Hallahan said, to protect themselves against the day-to-day exposure to so-called "free radicals" produced as a byproduct of inflammation and other normal biologic processes.

The researchers found that radiation activates a biochemical signalling pathway involving the proteins known as PI3K and Akt. This pathway then makes the endothelial cells lining the blood vessels resistant to radiation by activating a cell survival pathway. "We tested whether we could reverse the blood vessels' resistance to radiation therapy by inhibiting this pathway," Hallahan said. "We found inhibitors made tumor blood vessels more sensitive to radiation."

The scientists investigated two selective enzyme inhibitors that target this pathway, wortmannin and LY294002. In cell cultures, the researchers found that use of these drugs enhanced radiation-induced c

Contact: Cynthia Manley
Vanderbilt University Medical Center

Page: 1 2

Related medicine news :

1. Blocking molecules protects health of implants
2. Blocking selected neurotransmitter activity may decrease alcohol consumption
3. Blocking immune response to spinal cord injury can improve chances for recovery
4. Blocking enzyme found to ease anxiety without causing sedation
5. Blocking adhesion protein may reduce lung damage from radiation
6. Blocking gene may reduce lung scarring caused by radiation therapy
7. Mayo Clinic discovers new pathway against pancreatic cancer
8. Newly discovered pathway might help in design of cancer drugs
9. New math model of heart cell has novel calcium pathway
10. Discovery of pathway in learning impairment caused by liver disease may lead to drug treatment
11. Breast cancer may be uniquely sensitive to inhibitors of PI3K pathway

Post Your Comments:

(Date:6/2/2020)... ... June 02, 2020 , ... Join Nagy Habib, Professor of ... R&D, HalioDx in a live webinar on Monday, June ... has proved to be immensely informative in the context of clinical trials. Multiplex ...
(Date:5/30/2020)... ... , ... In appreciation for all the dedication and hard work first responders ... a $500 bonus towards the lease or purchase of a new or unused Hyundai ... , To qualify for this offer, individuals must be active as a police officer, ...
(Date:5/27/2020)... (PRWEB) , ... May 27, 2020 , ... ... announces that it is now manufacturing face shields to be used as ... that causes COVID-19. These face shields are single use, made to be worn ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... leading RevSpring solutions—Talksoft® patient messaging and IVR Advantage™--for Loyale customers. Talksoft pre-service ... automated and precise texts, IVR reminders and email messages tailored to each ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... to the CRC’s Guide to Coordinating Clinical Research, CenterWatch eLearning , ... management, The CRC Trainer: An Interactive Companion to the CRC’s Guide to ...
Breaking Medicine News(10 mins):
(Date:6/2/2020)... WEST CHESTER, Ohio (PRWEB) , ... June 02, ... ... and research agents, as well as screening tools, has strengthened its commitment to ... Xenometrix products are made for use in molecular pharmacology, early stages of drug ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... funding transformational early-phase cancer research, is excited to announce the launch of a ... advance cancer science and care. , The COVID-19 pandemic has resulted in ...
(Date:5/28/2020)... BROWNS MILLS, N.J. (PRWEB) , ... May 28, ... ... only specialty heart, lung, and vascular hospital, and an Alliance member of the ... patient monitoring for patients diagnosed with chronic obstructive pulmonary disease (COPD). , COPD ...
Breaking Medicine Technology:
Cached News: